Monitoring of anemia, the most frequent side-effect of antiviral therapy in hepatitis C virus (HCV)-infected liver transplant recipients, requires frequent blood tests and medical visits. The primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback